Viewing StudyNCT06466382

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 10:54 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06466382
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-05-21
Brief Title: OV Precision Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
Sponsor: Swiss GO Trial Group
Organization: Swiss GO Trial Group
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Ovarian Neoplasm Epithelial
Fallopian Tube Neoplasms
Ovarian Endometrioid Carcinoma
High-grade Serous Ovarian Carcinoma HGSOC
Keywords:
Name View
Primary ovarian cancer OC View
Treatment naiive View
Multi-modal tumor profiling View
Treatment recommendation process View
Multi-disciplinary tumor board View
Patient benefit View
Quality of Life QoL View
Patient-personalized therapy View